SQZ Biotech
SQZ Biotech sold its assets, including intellectual property and Cell Squeeze® technology, to STEMCELL Technologies Canada Acquisitions, Inc. on March 4, 2024, and subsequently filed for dissolution in Delaware.
Company Overview
SQZ Biotech was a biotechnology company known for its innovative Cell Squeeze® technology. The company focused on developing methods for cell therapy and other biological applications. On March 4, 2024, SQZ Biotech sold substantially all of its assets, including its intellectual property and proprietary Cell Squeeze® technology, to STEMCELL Technologies Canada Acquisitions, Inc.
Major Transaction
On March 4, 2024, SQZ Biotech completed a significant transaction by selling substantially all of its assets, including its intellectual property and Cell Squeeze® technology, to STEMCELL Technologies Canada Acquisitions, Inc. This sale marked a pivotal moment for the company, transitioning its core assets to another leading entity in the field of biotechnology.
Dissolution
Following the sale of its key assets, SQZ Biotech filed a Certificate of Dissolution with the Secretary of State of the State of Delaware. This legal step finalized the process of dissolving the company, ceasing its operations, and winding down its affairs.